||Introduction by Course Co-Directors
Charles J. Kahi, MD, MSc, FACG and Neil H. Stollman, MD, FACG
||Session 2A: Inflammatory Bowel Disease
Moderator: Sunanda V. Kane, MD, MSPH, FACG
- Biologic-Based Therapies in IBD
Sunanda V. Kane, MD, MSPH, FACG
Review current biologic agents for IBD, including biosimilars.
- Non-Biologic-Based Therapies in IBD
Ashwin N. Ananthakrishnan, MD, MPH
Describe the role of non-biologic agents including thiopurines, novel molecules, and non-pharmacologic options (diet, complementary medicine, and FMT) in managing IBD.
- Quality in IBD Care, From Monitoring to Maintenance
Millie D. Long, MD, MPH, FACG
Assess strategies to optimize health maintenance in IBD patients including vaccinations, bone loss prevention, and monitoring of disease activity and drug levels.
- Endoscopy in IBD
Francis A. Farraye, MD, MSc, FACG
Discuss the role of endoscopy in IBD patients, including assessment of disease activity, therapy of strictures, and dysplasia surveillance.
- Panel Q & A
||Session 2B: Colorectal Cancer Prevention
Moderator: Douglas K. Rex, MD, MACG
- Colorectal Cancer Prevention in 2018
Jason A. Dominitz, MD, MHS
Present an overview of the current status of CRC prevention in the U.S., including screening options and strategies to improve participation.
- Personalized CRC Screening and Surveillance in the Average-Risk Patient
Douglas J. Robertson, MD, MPH
Identify the best CRC screening test based on personal demographic and clinical features, and when to start and stop screening.
- Recognition and Management of the Patient at Increased CRC Risk
Aasma Shaukat, MD, MPH, FACG
Recognize patients at increased CRC risk due to family history and genetic causes, and implement appropriate surveillance.
- Optimal Colonoscopy Technique and Polypectomy
Douglas K. Rex, MD, MACG
Discuss the elements of high-quality colonoscopy, and polypectomy strategies based on polyp characteristics.
- Colonoscopy Quality: Measures and Systems
Irving M. Pike, MD, FACG
Understand and apply colonoscopy quality standards and requirements.
- Panel Q & A
||Break for Learning Luncheons
||Sunday Optional Learning Luncheons – Choose from 12
(You must register separately for learning lunches during the registration process.)
- Diverticular Disease Update 2018
Neil H. Stollman, MD, FACG
Summarize new thinking in the role of antibiotics for acute diverticulitis and care of patients with SUDD and SCAD.
- Endoscopic and Surgical Approaches for Obesity
Christopher C. Thompson, MD, MSc, FACG
Assess the role, benefits, and risks of endoscopic and surgical approaches to the treatment of obesity.
- Bowel Preparation Strategies: Routine to Challenging
Brennan M. Spiegel, MD, MSHS, FACG
Present current agents and strategies to optimize bowel preparation quality, including difficult-to-prep patients.
- Microscopic and Drug-Induced Colitis
David S. Weinberg, MD, MSc
Review the etiologies, diagnostic approaches, and treatment options for microscopic and drug-induced colitis.
- Hepatitis B Reactivation
David E. Bernstein, MD, FACG
Identify management of HBV reactivation in patients with immunosuppression and during pregnancy.
- Endoscopic Treatment of Pancreatobiliary Cancers
Douglas G. Adler, MD, FACG
Provide an overview of the endoscopic treatment of patients with pancreatobiliary cancers.
- Celiac and Gluten Sensitivity
Amy S. Oxentenko, MD, FACG
List practical approaches to the diagnosis and management of patients with celiac disease and non-celiac gluten sensitivity.
- Public Policy Update 2018
Costas H. Kefalas, MD, MMM, FACG
Review recent public policy issues of concern to the gastroenterologist.
- Achalasia and Its Variants
Marcelo F. Vela, MD, MSCR, FACG
Provide an overview of the diagnosis of achalasia and subtypes including GEJ outflow obstruction, and their treatment.
- Challenging IBD Situations
David T. Rubin, MD, FACG
Discuss the optimal approaches to patients with anti-TNF refractory disease, hospitalized patients with severe IBD, post-surgical patients, and those who wish to stop therapy.
- Serrated Polyps and the Serrated Polyposis Syndrome
Carol A. Burke, MD, FACG
Review serrated polyps, and recognition and management of serrated polyposis syndrome.
- Chronic Diarrhea
Christina M. Surawicz, MD, MACG
Explain practical diagnostic and therapeutic approaches to the patient with chronic diarrhea.
||Simultaneous Symposia – Choose from 3
Symposium D: Endoscopy
Moderator: John J. Vargo, II, MD, MPH, FACG
- Sedation: Medical and Regulatory Update
John J. Vargo, II, MD, MPH, FACG
Summarize the medical and regulatory status of sedation for endoscopy in the U.S.
- Prevention of Post-Procedure Bleeding
Heiko Pohl, MD
Explain the peri-endoscopic management of antithrombotic agents, and endoscopic interventions to mitigate the risk of post-procedure bleeding.
- Taking Care of the Endoscopist
Amandeep K. Shergill, MD
Present ergonomic standards for the modern endoscopy unit, and strategies to maintain work-life balance and prevent burnout.
- Panel Q & A
Symposium E: Care of the Patient With Liver Disease
Moderator: Patrick S. Kamath, MD
- Preventive Care of the Cirrhotic Patient
Suthat Liangpunsakul, MD
Outline the optimal care of patients with cirrhosis, including prevention of complications and vaccinations.
- Alcoholic Liver Disease
Patrick S. Kamath, MD
Review the treatment of patients with alcoholic liver disease, including alcoholic hepatitis.
- Liver Transplantation: Selection and Controversies
Paul Y. Kwo, MD, FACG
Explain the process of selection for liver transplantation, and controversies associated with evolving guidelines.
- Panel Q & A
Symposium F: Motility
Moderator: Lawrence R. Schiller, MD, MACG
- Chronic Constipation: Work-up and Treatment
Lawrence R. Schiller, MD, MACG
Outline the diagnostic and therapeutic approach to chronic constipation.
- Delayed Gastric Emptying: Diagnosis and Treatment
Michael Camilleri, MD, FACG
Review progress in the diagnosis and treatment of delayed gastric emptying.
- Esophageal Motility Disorders Not Named Achalasia
Felice Schnoll-Sussman, MD, FACG
Understand the terminology, diagnosis, and treatment of non-achalasia esophageal motility disorders.
- Panel Q & A
||Session 2C: Esophagus and Stomach
Moderator: Nicholas J. Shaheen, MD, MPH, FACG
- PPI Risks: Separating Fact From Fiction
Philip O. Katz, MD, MACG
Provide an evidence-based guide to risks associated with PPI use.
- Premalignant Lesions of the Esophagus
Nicholas J. Shaheen, MD, MPH, FACG
Discuss treatment strategies in patients with Barrett’s esophagus and esophageal squamous neoplasia.
- Premalignant Lesions and Polyps of the Stomach
Douglas R. Morgan, MD, MPH, FACG
Explain the approach to patients with gastric intestinal metaplasia and gastric polyps.
- Panel Q & A
||Take-home Pearls: What Did We Learn Today?
Charles J. Kahi, MD, MSc, FACG, and Neil H. Stollman, MD, FACG
Review important and practical take-home messages from today’s talks.
||Postgraduate Course Adjourns